Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great point--completely New science
"In contemplating today’s PR, it occurred to me that this news is not just about non-invasive blood glucose monitoring. This is independent verification of a scientific breakthrough:
Radio Frequency spectroscopy in the identification and precise measurement of analytes in fluid. Huge."
So Immature. Stop the nonsense. Take up reading the SEC documents.
All you have to do is read the SEC filings which contains all the details.
We have had two filings within the last week. Wealth of information.
I thought Tyler no longer works at Know. Right?
Covid. Google Covid Mayo.
News that Mayo will start testing finally
Know Labs Confirms Particle Bulb Kills SARS-CoV-2 News
They raise $ 14 million and are ready to launch Particle and everyone here has given up.............
$LXXGF - 100 Million Market Cap
Rapid RT-qPCR Genetic analyzer for detecting any DNA/RNA target in humans, animals, food safety, water, research, agriculture, cannabis AND Open Access for Anything Else (ie Sepsis)
From Jamaica on Lexagene
$ZOM - 2 Billion Market Cap Rapid Immuno-Assay for diagnosing thyroid + adrenal disease in pets
VS
$LXXGF - 100 Million Market Cap Rapid RT-qPCR Genetic analyzer for detecting any DNA/RNA target in humans, animals, food safety, water, research, agriculture, cannabis AND Open Access for Anything Else (ie Sepsis)
You decide!
From Jamaica on Lexagene
Agree totally.
How about a piece by WSJ reporter Chris Mims?
tps://www.wsj.com/articles/what-it-will-take-to-make-the-indoors-feel-safe-again-11591966803
What It Will Take to Make the Indoors Feel Safe Again
christopher.mims@wsj.com
Anyone know why they did not do a press release?
Seems strange.
Particle has launched.
https://www.particlebulb.com/
“Particle is the only disinfecting device leveraging UV technology that I would trust around my family. It is effective and safe.”
According to the Texas Biomed data shown above, at a power level of (only) 0.5 watts per square meter, Particle inactivates Covid by 94.7% at 5 hours, 99.2% at 6 hours and 99.9% at 8 hours.
Any license deal I am sure would have to be an exclusive one. Difficult to imagine two people marketing Uband.
Wasn't that almost two years ago? Are you implying no progress? They have to be way beyond this point.
IMHO
Apple or anyone would want an exclusive license which does not make sense for Know or its shareholders.
Spin the 80% of Particle off to Know Shareholders
Spin the non-medical Know Tech off to Know Shareholders
Sell the Medical Apps of Know Tech for $$$$ in the form of stock of acquirer making the acquisition non-taxable
The Know Medical Apps need $Billions behind it. Two people in the garage does not work. The UBand will be redone to whatever the acquirer desires.
Think of the Apple Iphone. Is the UBand the Apple Iphone? No
Why would Know be interested in uplifting to a major exchange if they were going to do something with Apple? They would not uplift.
Why not do something with Apple now????
Apple can throw billions at this to get to the market.
Particle, Inc.X
Formed in May 2020 and built upon the intellectual property of Know Labs, the independent team at Particle, Inc. has worked for the past 9 months to bring to market a disinfecting light bulb that can screw into existing fixtures in your home, office, or business. The Particle™ bulb is a hybrid light bulb that emits warm white light for everyday use and can kill viruses, bacteria, and germs, without harm to you or your family.
Through internal preliminary testing, Particle, Inc. has confirmed the bulb’s efficacy in disinfecting common germs such as E. coli and Staphylococcus. A world renowned, CDC-regulated biosafety level-4 laboratory is currently testing the Particle bulb’s ability to deactivate SARS-CoV-2, the virus that causes COVID-19.
Phil Bosua, Know Labs CEO and the inventor behind the first smart light bulb stated, “I had previously developed a light bulb that kills viruses and bacteria. When the coronavirus pandemic swept the world, we decided the time was right to truly revolutionize lighting as we know it. All of the internal testing we have conducted has been extremely positive and we expect results from an independent laboratory in the coming weeks. We brought together a talented team that is excited to introduce the Particle bulb to the market. It is the first of several products from Particle that I believe will make the space you inhabit safer for you and your family.”
“We believe Particle is the world’s first hybrid light bulb that blends everyday light with disinfecting power, giving it not just a pleasing aesthetic but also valuable utility, opening the door to a cleaner life.” – Phil Bosua, Know Labs, Inc. CEO
Actually Particle is 80% owned--rest to investors and insiders.
Mantix Are you not also in this?
Dr. Jack Regan BioPub.co Presents YouTube: Catching up with LexaGene (TSX-V: LXG; OTCQB: LXXGF)
At 1:58 Dr. Regan compares Lexagene to competitor Genmark (GNMK).
At 1:54 Dr. Regan talks about suitors.
Write up
https://www.dropbox.com/scl/fi/devom3kseou1rswtxqf2o/Document.docx?dl=0&rlkey=xhzktsekqgjspshx4p35wl3l2
Are you a shareholder of Particle TB? Any thoughts there?
What will happen to the non-medical tech applications?
Bravo ! Very well put. Thank you.
Just trying to be informed of the status.
LOL I guess that is a long way to say NO. Thanks
Sorry but we are not "pretty close."
Has anyone talked to Ron Erickson in last 6 months? Is he still involved with Know Labs? Same question regarding Phil Bosua.
The same message on facebook for years. They are still perfecting the frankenstein model.
Congrats to Apple. We all knew they would get there.
Apple rumored to be bringing glucose monitoring to Apple Watch Series 7.
http://appleinsider.com/articles/21/01/25/apple-watch-series-7-rumor-claims-glucose-monitoring-is-on-the-way
Apple has secured various patents relating to blood sugar monitoring without drawing blood, including one from 2019 that analyzes body odor for changes. Another employed an optical system for absorption spectroscopy, to analyze materials in the blood.
Reports going as far back as 2017 also claim CEO Tim Cook has taken part in non-intrusive glucose monitoring tests, with Cook also admitting having worn a continuous glucose monitor for a few weeks.
Tokyo Company Unveils World's First Wearable Glucose MonitorThe wearable provides 24/7 non-invasive needleless monitoring of blood glucose levels.
The new wearable uses the company's patented spectrum technology to accurately measure glucose in a person's bloodstream through the skin without having to use a needle.Using the technology, diabetic patients will be able to replace the daily routine of using a needle for measurements with simply strapping on a wristwatch-like wearable device.Eliminating the pain of daily needle use for diabetic patients Quantum Operation is showcasing its new technology at this year's CES alongside a similar oxygen saturation measuring system sensor (SpO2) wearable device.
Know just gave us a corporate update. Doubt we will sell one for a few months.
No one can share as under NDA. As said hopefully in next month or two company will be roll out.
Particle Draft Video out. Hopefully going to launch soon.
I thought you were under a NDA? Everything is speculation.
6) Ron Erickson was born December 24, 1943 or he will be 77.
7) Phil Bosua is a serial entrepreneur. He has already moved on to Particle.
8) No CFO has been hired. Interim CFO is Ron Erickson.
9) No Buyer is going to limit the acquisition to just Glucose
Polyphemus
Here is the ordering information for AC5.
Please let us know your findings after you order AND TALK WITH MANAGEMENT.
https://www.archtherapeutics.com/products/ordering-information ;
Ordering Information
AC5 Advanced Wound System
Available in the USA
Item Number AC5-1001AC5 Topical Hemostat
Available in Europe
Item Number AC5-2001
To place orders:
Email: orders@archtherapeutics.com
Phone: (617) 431-2317
Any discussion of Know is considered "pumpling" here. So please refrain from all such discussions.
BTW IMHO no NYSE uplist on horizon.
What should be discussed is the non-medical apps of Know Tech. What happens to those?
Agree except Mayo is not testing a Frankenstein but the real Uband. Whoever buys out will redesign the Uband to their own specs.
Before Mayo took on the project they pretested the Uband. Mayo takes no chances on new tech.
Purpose of Mayo test is to demonstrate to potential buyers.
FDA clearance will be by new buyers.
Read about Particle in the Form 10-Q.
CFO Rick Davis ALWAYS CALLS BACK 617 431-2308
As someone experienced in chronic wound care, I know that a wound dressing by itself does not produce closures of persistent pressure sores. Practice is to address a constellation of factors contributing to the continuing wound. Competent clinicians will routinely address the following:
The million $ question is why you have not tested the product? Seems rather elementary. Why have you not talked with management about answers? Makes no sense to me.
On this board for years yet refuse to talk with management?
Conducting due diligence here? Really?
Rather than constantly speculating why not just call Terry Norchi at
617-431-2316 and get some REAL answers ??
Lightning to strike again
CODX discussed here:
The company is aiming to work with the FDA for an Emergency Use Authorization (EUA) to proceed with COVID-19 testing, and then work with the Centers for Disease Control and Prevention (NASDAQ:CDC) to increase its other human clinical diagnostics testing indications.
To provide an appropriate example of what an FDA approval could mean for a small developing company such as LexaGene, we can look at Co-Diagnostics (Nasdaq: CODX), that went up from just under $1.00 per share to around $3.50 upon an expected FDA approval, and later skyrocketed to $17.60 upon the actual FDA approval, and even reached irrational record highs of $30.Just like any biotech company in the development stage, any good news could see the per share price rapidly increase, just like what we saw happened with CODX.
LexaGene’s share price is a bargain at this level (~$0.60), and has the potential to become a $4B-$5B market cap company if growth is managed well.
https://seekingalpha.com/instablog/52496833-agni-research/5497965-lexagene-set-to-disrupt-veterinary-diagnostics-market
LexaGene Set To Disrupt Veterinary Diagnostics Market.
FEZZ What happened with HALO? Use to follow you closely?
Poly So how much patience as far as time? Half a year?
Was it not you who was discussing
https://www.dropbox.com/scl/fi/696dvm30x2e298qivgige/Lexagene-Holdings-2.docx?dl=0&rlkey=7v7uz9zg5pkheikdwgpvj45tb